かんぽ生命 (7181) 「Overweight」へ引き上げ、リスクリワード改善で割安感見出しやすく

Research evidence excerpt

かんぽ生命 (7181) 「Overweight」へ引き上げ、リスクリワード改善で割安感見出しやすく

JP ٜٓ؝٤証券株式会社 ؓةؓقبنؔشؠ 株式調査部

佐藤 耕喜AC 2026 年 6 月 23 日 J P M O R G A N

(81-3) 6736-8609

koki.sato@jpmorgan.com

Argentina: JPMorgan Chase Bank N.A Sucursal Buenos Aires is regulated by Banco Central de la República Argentina (˘BCRA˙- Central Bank of

Argentina) and Comisión Nacional de Valores (˘CNV˙- Argentinian Securities Commission - ALYC y AN Integral N°51).

Australia: J.P. Morgan Securities Australia Limited (˘JPMSAL˙) (ABN 61 003 245 234/AFS Licence No: 238066) is regulated by the Australian

Securities and Investments Commission and is a Market Participant of ASX Limited, a Clearing and Settlement Participant of ASX Clear Pty Limited

and a Clearing Participant of ASX Clear (Futures) Pty Limited. This material is issued and distributed in Australia by or on behalf of JPMSAL only to

"wholesale clients" (as defined in section 761G of the Corporations Act 2001). A list of all financial products covered can be found by visiting

https://www.jpmm.com/research/disclosures. J.P. Morgan seeks to cover companies of relevance to the domestic and international investor base

across all Global Industry Classification Standard (GICS) sectors, as well as across a range of market capitalisation sizes. If applicable, in the course of

conducting public side due diligence on the subject company(ies), the Research Analyst team may at times perform such diligence through corporate

engagements such as site visits, discussions with company representatives, management presentations, etc. Research issued by JPMSAL has been

prepared in accordance with J.P. Morgan Australia˖s Research Independence Policy which can be found at the following link: J.P. Morgan Australia -

Research Independence Policy.

Brazil: Banco J.P. Morgan S.A.